COURTNEY HOOD: Open Payments
NPI 1972894442 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 21 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $465 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $205 |
| Novo Nordisk Inc | 3 | $66 |
| Lilly USA, LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: VRAYLAR, QULIPTA, UBRELVY, ZEPBOUND, Wegovy, REXULTI, NURTEC ODT, RELISTOR.
Industry payments across AL — which companies pay providers there.
